Publications by authors named "Huanjie Fu"

This study focused on examining the protection of QiShenYiQi dripping pills (QSYQ) against myocardial infarction (MI) and investigating its potential mechanisms. Ultra high performance liquid chromatography-q exactive-orbitrap high resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was employed to analyze potential active compounds of QSYQ. The targets of these compounds were predicted using an integrated method and cross-referenced with relevant databases to identify associated pathways.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on Huanglian Wendan (HLWD), a traditional Chinese medicine, to treat metabolic-associated fatty liver disease (MAFLD) and atherosclerosis, both common health issues that often occur together.
  • Researchers aimed to identify the effective compounds in HLWD and understand how they work against MAFLD and atherosclerosis, using advanced techniques like ultrahigh-performance liquid chromatography and network analysis.
  • The results revealed 18 active components in HLWD and demonstrated that it effectively improves liver health and reduces body weight and blood lipids in a mouse model of MAFLD and atherosclerosis.
View Article and Find Full Text PDF

Background: Hypertension (HTN) and non-alcoholic fatty liver disease (NAFLD) frequently coexist and share pathophysiological symptoms. Based on the liver stiffness measurement and controlled attenuation parameter obtained by performing liver transient ultrasound elastography (TUE), we determined the relationship between HTN status and the rates of liver steatosis and fibrosis in this study.

Methods: To perform this cross-sectional study, data were obtained from the National Health and Nutrition Examination Survey for 2017-March 2020 Pre-pandemic cycle.

View Article and Find Full Text PDF

Myocardial ischemia/reperfusion (I/R) injury is associated with multiple serious clinical manifestations. Autophagy is upregulated in a short period of ischemia and further enhanced during reperfusion phase, which was considered as a "double-edged sword" in the pathological process of myocardial I/R injury. In addition, NLRP3 inflammasome triggers myocardial inflammatory response, which leads to cardiomyocyte death via pyroptosis and promotes subsequent myocardial remodelling.

View Article and Find Full Text PDF

Myocardial infarction (MI) is a complicated pathology triggered by numerous environmental and genetic factors. Understanding the effect of epigenetic regulation mechanisms on the cardiovascular disease would advance the field and promote prophylactic methods targeting epigenetic mechanisms. Genetic screening guides individualised MI therapies and surveillance.

View Article and Find Full Text PDF